Several studies identified the expression of Ki-67 as the prognostic biomarker of various cancers such as meningioma, glioma, renal cells carcinoma, thyroid cancer, prostate cancer, and bladder cancer [12, 175–179]. Here, MKI67 is linked to prostate cancer.